In particular, HIF-1α, a master regulator of glycolysis, is highly expressed by macrophages in the RA synovium, compared to macrophages in OA and healthy control synovium (Hollander et al., 2001) suggesting HIF-1α as novel potential therapeutic target. The gene discussed is HIF1A; the disease is rheumatoid arthritis.